BML210 | B1128

BML-210 (also known as CAY10433), is a histone deacetylase (HDAC) inhibitor. BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.

BML-210 (also known as CAY10433), is a histone deacetylase (HDAC) inhibitor. BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.

B1128 | BML210 DataSheet

Alternate Name/Synonyms: N-(2-aminophenyl)-N'-phenyl-octanediamide; CAY10433

Appearance: White to off-white solid

Formulation: N/A

CAS Number: 537034-17-6

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₀H₂₅N₃O₂

Molecular Weight: 339.43

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (>20 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A histone deacetylase (HDAC) inhibitor.

MDL Number: MFCD02062139

PubChem CID: 9543540

SMILES: C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NC2=CC=CC=C2N

InChi: InChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)

InChi Key: RFLHBLWLFUFFDZ-UHFFFAOYSA-N